Cargando…
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
BACKGROUND: The main psychoactive component of cannabis, delta-9-tetrahydrocannabinol (THC), can impair driving performance. Cannabidiol (CBD), a non-intoxicating cannabis component, is thought to mitigate certain adverse effects of THC. It is possible then that cannabis containing equivalent CBD an...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695367/ https://www.ncbi.nlm.nih.gov/pubmed/31044290 http://dx.doi.org/10.1007/s00213-019-05246-8 |
_version_ | 1783444023071997952 |
---|---|
author | Arkell, Thomas R. Lintzeris, Nicholas Kevin, Richard C. Ramaekers, Johannes G. Vandrey, Ryan Irwin, Christopher Haber, Paul S. McGregor, Iain S. |
author_facet | Arkell, Thomas R. Lintzeris, Nicholas Kevin, Richard C. Ramaekers, Johannes G. Vandrey, Ryan Irwin, Christopher Haber, Paul S. McGregor, Iain S. |
author_sort | Arkell, Thomas R. |
collection | PubMed |
description | BACKGROUND: The main psychoactive component of cannabis, delta-9-tetrahydrocannabinol (THC), can impair driving performance. Cannabidiol (CBD), a non-intoxicating cannabis component, is thought to mitigate certain adverse effects of THC. It is possible then that cannabis containing equivalent CBD and THC will differentially affect driving and cognition relative to THC-dominant cannabis. AIMS: The present study investigated and compared the effects of THC-dominant and THC/CBD equivalent cannabis on simulated driving and cognitive performance. METHODS: In a randomized, double-blind, within-subjects crossover design, healthy volunteers (n = 14) with a history of light cannabis use attended three outpatient experimental test sessions in which simulated driving and cognitive performance were assessed at two timepoints (20–60 min and 200–240 min) following vaporization of 125 mg THC-dominant (11% THC; < 1% CBD), THC/CBD equivalent (11% THC, 11% CBD), or placebo (< 1% THC/CBD) cannabis. RESULTS/OUTCOMES: Both active cannabis types increased lane weaving during a car-following task but had little effect on other driving performance measures. Active cannabis types impaired performance on the Digit Symbol Substitution Task (DSST), Divided Attention Task (DAT) and Paced Auditory Serial Addition Task (PASAT) with impairment on the latter two tasks worse with THC/CBD equivalent cannabis. Subjective drug effects (e.g., “stoned”) and confidence in driving ability did not vary with CBD content. Peak plasma THC concentrations were higher following THC/CBD equivalent cannabis relative to THC-dominant cannabis, suggesting a possible pharmacokinetic interaction. CONCLUSIONS/INTERPRETATION: Cannabis containing equivalent concentrations of CBD and THC appears no less impairing than THC-dominant cannabis, and in some circumstances, CBD may actually exacerbate THC-induced impairment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00213-019-05246-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6695367 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-66953672019-08-28 Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition Arkell, Thomas R. Lintzeris, Nicholas Kevin, Richard C. Ramaekers, Johannes G. Vandrey, Ryan Irwin, Christopher Haber, Paul S. McGregor, Iain S. Psychopharmacology (Berl) Original Investigation BACKGROUND: The main psychoactive component of cannabis, delta-9-tetrahydrocannabinol (THC), can impair driving performance. Cannabidiol (CBD), a non-intoxicating cannabis component, is thought to mitigate certain adverse effects of THC. It is possible then that cannabis containing equivalent CBD and THC will differentially affect driving and cognition relative to THC-dominant cannabis. AIMS: The present study investigated and compared the effects of THC-dominant and THC/CBD equivalent cannabis on simulated driving and cognitive performance. METHODS: In a randomized, double-blind, within-subjects crossover design, healthy volunteers (n = 14) with a history of light cannabis use attended three outpatient experimental test sessions in which simulated driving and cognitive performance were assessed at two timepoints (20–60 min and 200–240 min) following vaporization of 125 mg THC-dominant (11% THC; < 1% CBD), THC/CBD equivalent (11% THC, 11% CBD), or placebo (< 1% THC/CBD) cannabis. RESULTS/OUTCOMES: Both active cannabis types increased lane weaving during a car-following task but had little effect on other driving performance measures. Active cannabis types impaired performance on the Digit Symbol Substitution Task (DSST), Divided Attention Task (DAT) and Paced Auditory Serial Addition Task (PASAT) with impairment on the latter two tasks worse with THC/CBD equivalent cannabis. Subjective drug effects (e.g., “stoned”) and confidence in driving ability did not vary with CBD content. Peak plasma THC concentrations were higher following THC/CBD equivalent cannabis relative to THC-dominant cannabis, suggesting a possible pharmacokinetic interaction. CONCLUSIONS/INTERPRETATION: Cannabis containing equivalent concentrations of CBD and THC appears no less impairing than THC-dominant cannabis, and in some circumstances, CBD may actually exacerbate THC-induced impairment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00213-019-05246-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-05-01 2019 /pmc/articles/PMC6695367/ /pubmed/31044290 http://dx.doi.org/10.1007/s00213-019-05246-8 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Investigation Arkell, Thomas R. Lintzeris, Nicholas Kevin, Richard C. Ramaekers, Johannes G. Vandrey, Ryan Irwin, Christopher Haber, Paul S. McGregor, Iain S. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition |
title | Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition |
title_full | Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition |
title_fullStr | Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition |
title_full_unstemmed | Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition |
title_short | Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition |
title_sort | cannabidiol (cbd) content in vaporized cannabis does not prevent tetrahydrocannabinol (thc)-induced impairment of driving and cognition |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695367/ https://www.ncbi.nlm.nih.gov/pubmed/31044290 http://dx.doi.org/10.1007/s00213-019-05246-8 |
work_keys_str_mv | AT arkellthomasr cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition AT lintzerisnicholas cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition AT kevinrichardc cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition AT ramaekersjohannesg cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition AT vandreyryan cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition AT irwinchristopher cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition AT haberpauls cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition AT mcgregoriains cannabidiolcbdcontentinvaporizedcannabisdoesnotpreventtetrahydrocannabinolthcinducedimpairmentofdrivingandcognition |